FDA To Manufacturers: Describe Adverse Events More Fully
This article was originally published in The Silver Sheet
Executive SummaryFDA URGES FIRMS TO COMPLETE ADVERSE EVENT REPORT NARRATIVES so the agency will better understand the nature of the incident. Meanwhile, a new chart designed by CDRH's Office of Surveillance & Biometrics describes what FDA does with the reports it receives
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.